Regulation of inflammatory cytokines in human immunocompetent cells by propranolol in vitro

Fatemeh Hajighasemi (Tehran, Islamic Republic of Iran), Fatemeh Hajighasemi, Abbas Mirshafiey

Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Session: Laboratory tests and cell biology in allergy and immunology
Session type: Thematic Poster
Number: 1083
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fatemeh Hajighasemi (Tehran, Islamic Republic of Iran), Fatemeh Hajighasemi, Abbas Mirshafiey. Regulation of inflammatory cytokines in human immunocompetent cells by propranolol in vitro. Eur Respir J 2016; 48: Suppl. 60, 1083

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differential effects of simvastatin and dexamethasone on TLR3-induced anti-viral cytokines in asthmatic epithelium
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013

Anti-inflammatory effects of the novel PDE4 inhibitor CHF6001 on virus inducible cytokines
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014

Osteopontin binds and modulate the antibacterial action of eosinophil-recruiting chemokines during allergic inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

Effect of verapamil on vascular endothelial growth factor production in immunocompetent cells
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015

Glucocorticoid-induced transcriptional regulators in human airway cells and airways
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016

Inhibition of matrix metalloproteinase-2 activity by propranolol in immunocompetent cells
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013

Imbalance of pro-inflammatory and anti-inflammatory markers on circulating dendritic cells in COPD
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014

Nociceptin modulates the inflammatory immune microenvironment in a conventional murine model of asthma
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015


An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013

Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015

Importance of levels production of Il-4 in the pathogenesis and formation of the phenotype of asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Effect of the combination of doxofylline and montelukast on LPS-induced leukocyte migration to the lung
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

Systemic characterization of macrophage phenotypes in allergic airway inflammation
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014

ARRY-502, a potent, selective, oral CRTh2 antagonist reduces Th2 mediators in patients with mild to moderate Th2-driven asthma
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014


Aquaporin-3 potentiates murine asthma through mediating T-cell trafficking and chemokine production
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Immunoregulatory effects of ceftaroline in airway epithelial cells and in immunocompetent cells
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

Simvastatin suppresses the activity of Th2 and Tc2 cells in atopic asthma and in COPD
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014

Enhanced anti-inflammatory gene expression in humans following inhaled budesonide
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


The monocyte-dependent immune response to bacterial infections is systemically suppressed in COPD
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014